Development of BCPDA-Eu3+-BAS labeled hepatitis B surface antibodies

Wenjia Tan , Zhixia Sun , Lili Xuan , Junling Li , Wenbing Xie , Chengyan He , Lihua Pan

Chemical Research in Chinese Universities ›› 2018, Vol. 34 ›› Issue (1) : 24 -27.

PDF
Chemical Research in Chinese Universities ›› 2018, Vol. 34 ›› Issue (1) : 24 -27. DOI: 10.1007/s40242-018-7295-y
Article

Development of BCPDA-Eu3+-BAS labeled hepatitis B surface antibodies

Author information +
History +
PDF

Abstract

The effect of the chelating agent 4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid (BCPDA) labeled hepatitis B surface antibodies(HBsAb) on time-resolved fluoroimmunoassays(TRFIA) was investigated. The labeling detection method was established. The biotin-streptavidin(BAS) system was introduced, and the multi-stage amplification effect of the BAS system was analyzed. It is found that the BCPDA-Eu3+-HBsAb-BAS fluorescent marker can emit strong fluorescence. Compared to BCPDA-Eu3+-HBsAb, BCPDA-Eu3+-HBsAb-BAS demonstrates an enhanced fluorescence intensity by over 10 times. This study provides a guidance for the next generation non-radio immunoassays in clinical diagnosis.

Keywords

Time-resolved fluorescence immunoassay / Biotin / Streptavidin

Cite this article

Download citation ▾
Wenjia Tan, Zhixia Sun, Lili Xuan, Junling Li, Wenbing Xie, Chengyan He, Lihua Pan. Development of BCPDA-Eu3+-BAS labeled hepatitis B surface antibodies. Chemical Research in Chinese Universities, 2018, 34(1): 24-27 DOI:10.1007/s40242-018-7295-y

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Camacho S. A., Sobral-Filho R. G., Aoki P. H. B., Constantino C. J. L., Brolo A. G. Analyst, 2017, 142(15): 2717.

[2]

Li X., Chen H., Wei J., Lv N., You L. Clin. Chem. Lab. Med., 2011, 49(9): 1533.

[3]

Aydin S. Peptides, 2015, 72: 4.

[4]

Nakagawa M., Karashima T., Kamada M., Yoshida E., Yoshimura T., Nojima M., Inoue K., Shuin T., Seiki M., Koshikawa N. Biomark. Res., 2017, 5: 29.

[5]

Xu J., Wang L., Deng C., Hu X., Li R., Chen T., Ning D., Wu Y., Huang Y., Li X., Wu Z., Yu X., Li Y. Parasitol. Res., 2014, 113(1): 149.

[6]

Li T., Choi Y. H., Shin Y. B., Kim H. J., Kim M. G. Chemosphere, 2016, 150: 407.

[7]

Cywinski P. J., NchimiNono K., Charbonnie L. J., Hammann T., Lohmannsroben H. G. Phys. Chem. Chem. Phys., 2014, 16: 6060.

[8]

Chen J. J., Liu T. C., Liang Q. N., Dong Z. N., Wu Y. S., Li M. J. Med. Virol., 2015, 87(11): 1940.

[9]

Ding L., Chen Q., Fan W., Zou X. Ann. Diagn. Pathol., 2017, 29: 7.

[10]

He Q., Chen H., Nie L., Tang J., Xiao P. J. Nanosci. Nanotechnol., 2006, 6(1): 66.

[11]

Niu C. G., Liu J., Qin P. Z., Zeng G. M., Ruan M., He H. Anal. Bio-chem., 2011, 409(2): 244.

[12]

Pan L. H., An J. L., Xie W. B., Guan M. Spectroscopy and Spectral Analysis, 2004, 24(7): 795.

[13]

Bacigalupo M. A., Ius A., Simoni P., Piazza F., Roda A., Setchell K. D., Fresenius J. Anal. Chem., 2001, 370(1): 82.

[14]

Ius A., Bacigalupo M. A., Longhi R., Meroni G. Fresenius. J. Anal. Chem., 2000, 366(8): 869.

[15]

Pan L., Guo S., Duan T., An J., Xie W., Lin M. Anal. Sci., 2005, 21(6): 713.

[16]

He Y., Jiao B. Talanta, 2017, 163: 140.

[17]

Guo Q., Han J. J., Shan S., Liu D. F., Wu S. S., Xiong Y. H., Lai W. H. Biosens. Bioelectron., 2016, 86: 990.

[18]

Dou X. Q., Zhang J., Feng C. ACS Appl. Mater. Interfaces, 2015, 7(37): 20786.

[19]

Kim M. C., Hong M. H., Lee B. H., Choi H. J., Ko Y. M., Lee Y. K. Ann. Biomed. Eng., 2015, 43(12): 3004.

[20]

Sheng H., Hu Z. G., Liu J., Yuan F., Li M., Zou Y., Chen Y. J. Clin. Lab. Anal., 2015, 29(6): 474.

AI Summary AI Mindmap
PDF

120

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/